Orexigen Therapeutics, Inc. (OREX)

cashsage (80.35) Submitted: 11/24/2009 1:42:21 PM : Start Price: $6.74 OREX Score: -0.46

OREX has a too high valuation compared to its sales potential. It is also one of the most loss making companies at least until 2011.

TMFmrquakeroats (85.62) Submitted: 9/8/2009 9:59:28 AM : Start Price: $8.25 OREX Score: +28.25

Rated one star.

quinpeung (43.99) Submitted: 6/3/2009 2:21:12 PM : Start Price: $4.38 OREX Score: -37.10

Surprised that OREX rose back over the threshold. This stock will likely bounce up and down for the next few months as management hypes their marginal obesity candidate.

zzlangerhans (99.53) Submitted: 6/2/2009 10:53:01 PM : Start Price: $4.19 OREX Score: -44.04

I'm suspicious of strong upward moves in Orexigen given the weakness of the completed phase III trial of Contrave. The company has an opportunity to redeem itself in Q3 with additional phase III Contrave data as well as phase II data for Empatic, but I don't see current highs being sustained through that point.

albanyfx (30.34) Submitted: 2/29/2008 1:35:44 PM : Start Price: $12.68 OREX Score: +32.63

OREX management panicked and accepted any horrible deal to get their hands on some cash. But there are a whole host of medical, technology, finance, manufacturing and retail names out there that are starving for capital. And you better believe that once the next window opens in the coming weeks, most likely underwriters will be falling all over themselves to bring these guys to market and collect their fat fees.

This is fall down to ZERO!